Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hast

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Acta Medica Scandinavica|January 1, 1978
Increase in serum alkaline phosphatase (S-ALP) in chronic myelocytic leukemia--sign of drug-induced cholestasis?R Hast
Scandinavian Journal of Haematology|November 1, 1978
Studies on human preleukaemia. IV. Clinical and prognostic significance of sideroblasts in aregenerative anaemia with hypercellular bone marrowR Hast
Lakartidningen|April 30, 1980
[3 cases of pernicious anemia at the age of 30]R Hast
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Sideroblasts in myelodysplasia: their nature and clinical significanceR Hast
Medical Oncology (Northwood, London, England)|October 19, 1999
A strategy for erythropoietin treatment in myelodysplastic syndromesR Hast
Lakartidningen|January 10, 1998
[PNH--paroxysmal nocturnal hemoglobinuria. An old disease explained by new technology]R Hast
Lakartidningen|July 8, 2000
[Hematopoietic growth factors in oncology and hematology. Recommendations for more cost-efficient use]C Paul, R Hast
Leukemia Research|January 1, 1992
Therapeutic aspects of myelodysplastic syndromes in chronic phaseR Hast, E Hellström
Lakartidningen|March 25, 1992
[Erythropoietin is not only for patients with renal diseases--new indications in sight]R Hast, L Stenke
Acta Haematologica Polonica|January 1, 1991
Hematopoietic growth factors for the treatment of myelodysplastic syndromesR Hast, P Bernell
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Acta Medica Scandinavica|January 1, 1978
Increase in serum alkaline phosphatase (S-ALP) in chronic myelocytic leukemia--sign of drug-induced cholestasis?R Hast
Scandinavian Journal of Haematology|November 1, 1978
Studies on human preleukaemia. IV. Clinical and prognostic significance of sideroblasts in aregenerative anaemia with hypercellular bone marrowR Hast
Lakartidningen|April 30, 1980
[3 cases of pernicious anemia at the age of 30]R Hast
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Sideroblasts in myelodysplasia: their nature and clinical significanceR Hast
Medical Oncology (Northwood, London, England)|October 19, 1999
A strategy for erythropoietin treatment in myelodysplastic syndromesR Hast
Lakartidningen|January 10, 1998
[PNH--paroxysmal nocturnal hemoglobinuria. An old disease explained by new technology]R Hast
Lakartidningen|July 8, 2000
[Hematopoietic growth factors in oncology and hematology. Recommendations for more cost-efficient use]C Paul, R Hast
Leukemia Research|January 1, 1992
Therapeutic aspects of myelodysplastic syndromes in chronic phaseR Hast, E Hellström
Lakartidningen|March 25, 1992
[Erythropoietin is not only for patients with renal diseases--new indications in sight]R Hast, L Stenke
Acta Haematologica Polonica|January 1, 1991
Hematopoietic growth factors for the treatment of myelodysplastic syndromesR Hast, P Bernell
Pageof 11